News

The Member Spotlight is an ongoing Q&A series focused on getting to know the CASSS community. Today’s spotlight shines on John Kim, Director, Analytical Sciences at Teva Pharmaceuticals.

We are just back from a from another wonderful, but admittedly very different CMC and WCBP in Washington, DC. As a hybrid, it was our largest CMC/WCBP ever, with about 25% of the attendees in-person and the rest attending virtually.

CASSS honored Robert Sitrin, Ph.D. with its prestigious William S. Hancock Award for Outstanding Achievements in CMC Regulatory Science during last month’s WCBP 2022: Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products.

The CASSS Board of Directors announced the appointment of Nadine M. Ritter, Global Biotech Experts, LLC and Mark A. Schenerman, CMC Biotech-MAS Consulting as Distinguished Fellows.

CASSS is pleased to announce Andrew Chang and Jamie Moore have been elected and Kathy Lee reelected to the Board of Directors.

Last month, I shared how the CASSS board was reflecting on lessons learned over the past year. Heading in to 2022, the organization is turning its eyes forward.

The Member Spotlight is an ongoing Q&A series focused on getting to know the CASSS community. Today’s spotlight shines on Cammilla Gomes, Regulatory Policy Lead for Latin America at Roche.

The second year of the pandemic brought more challenges – from the rapid pace of work to carving out enough personal time. But there have also been opportunities and some important wins.

The Member Spotlight is an ongoing Q&A series focused on getting to know the CASSS community. Today’s spotlight shines on George Bou-Assaf, Senior Scientist at Biogen.

November means Thanksgiving in the United States. Regardless of where you are, it reminds us there's always something to be grateful for... The pandemic has made life much more challenging over the past year and a half, for everyone.